Showing results (1631-1640 of 15,705) with videos related to
Sort By:
Pageof 1,571
Oncology Letters|June 20, 2022
MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progressionYing Ye, Juhua Zhuang, Guoyu Wang, et al.Oncology Letters|June 20, 2022
Diagnostic value of abnormal chromosome 3p genes in small-cell lung cancerChunxu Ma, Jihua Zhao, Ying Wu, et al.Oncology Letters|June 20, 2022
ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cellsXiao Zhang, Yaping Bai, Wenhao Zhu, et al.Oncology Letters|June 20, 2022
LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancerXin Liu, Qiang Song, Daohan Wang, et al.Oncology Letters|June 20, 2022
Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancerDapeng Li, Dandan Wang, Shuai Feng, et al.Oncology Letters|June 28, 2022
Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinomaZhan Wang, Mingxin Zhang, Samuel Seery, et al.Oncology Letters|July 5, 2022
Identification and verification of the role of crucial genes through which methionine restriction inhibits the progression of colon cancer cellsLiqiang Zhou, Zhiqing Chen, Chuan LiuOncology Letters|July 5, 2022
Polo-like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancerZhengang Duan, Lei Cai, Jin Cao, et al.Oncology Letters|July 5, 2022
Coexistence of malignant ovarian Brenner tumor and borderline mucinous cystadenoma, combined with primary uterine corpus endometrioid carcinoma: A case report and literature reviewCancan Zou, Qiong Li, Jingbo Zhao, et al.Oncology Letters|June 29, 2022
Lentivirus-induced knockdown of IARS2 expression inhibits the proliferation and promotes the apoptosis of human osteosarcoma cellsQi Liu, Feng LinPageof 1,571